Endometriosis is a medical condition in
which the tissue that forms normal lining of uterus appears outside the
uterus cavity and may involve ovaries, bowel, or tissue lining of the
pelvic floor. This disease affects over 170 million women across the
globe. Endometriosis has an unclear etiology and complex symptoms.
Hence, the endometriosis treatment market is projected to grow
substantially due to increase in number of cases for endometriosis and
advancements in treatment technologies. Moreover, growing awareness
about endometriosis treatment among women, rising demand for treatment,
increasing incidence of endometriosis, and improvement in its diagnosis
methods have strengthened the endometriosis treatment market.
Currently, the endometriosis treatment
market is witnessing extensive research and development with significant
number of new product introduction. This encourages manufactures to
cater to the increasing customer demands. The endometriosis treatment
market is consolidated, with top industry players such as AbbVie,
Pfizer, Bayer HealthCare, AstraZeneca, and Takeda accounting for
majority share. Most of the companies undertake considerable research
efforts toward development of novel non-hormonal drugs, diagnostic and
surgical techniques, and substantial support in terms of funding. This
has fueled the growth of this market. Therefore, significant unmet needs
for curative treatment of endometriosis is likely to drive the market.
Growth of the global endometriosis market is likely to be driven by
emerging economies in Asia, where the disease prevalence is almost 10%
of the total female population of this region.
According to the National Center for
Biotechnology Information, endometriosis is estimated to affect 10% of
women in reproductive age, which increases gradually to 40% in
infertility patients. This explains the need of endometriosis treatment
in the region, and thereby the potential of endometriosis drugs in the
market. Therefore, rising incidence of endometriosis is a major factor
driving the endometriosis treatment market in the region. Other factors
boosting the endometriosis treatment market include rising demand for
advanced endometriosis treatment, intra-industry competition, and
increasing new entrants in the market. The endometriosis treatment
market is consolidated due to increase in inorganic growth activities
such as mergers and acquisitions. However, declining prices due to
increasing competition have impacted industry profit margins. Hence,
most of the players have adopted the strategy of increasing research
activities to develop novel products in the endometriosis treatment
market. The endometriosis treatment market has recorded continuous
growth in the past few years. Moreover, factors which declining cost of
endometriosis treatment, patent loss and increasing number of generic
drugs are driving the growth of endometriosis treatment market.
Increasing operational costs and rising number of new entrants such as
regional and multinational industry players are the key factors
hampering the growth of the endometriosis treatment market.
The global endometriosis treatment market has been segmented based on type of product and region. In terms of product, the endometriosis treatment market has been segmented into gonadotrophin releasing hormone agonists (GRH), non-steroidal anti-inflammatory drugs (NSAIDs), progestins, and contraceptive pills. Based on region, the endometriosis treatment market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to account for significant share of the endometriosis treatment market during the forecast period, followed by Europe and Asia Pacific. The market in Asia Pacific is projected to expand at a high CAGR during the forecast period. This report offers an extensive and in-depth assessment of the endometriosis treatment market and also contains situational analysis, facts, insights, historical data, and statistically supported market data validated through industry key opinion leaders. It also offers market estimations with the help of suitable assumptions and methodologies. The market research report contains in-depth analysis and thorough information about market segments such as product type, application, and region.
Key players operating in the global
endometriosis treatment market are Abbott Laboratories, Eli Lilly and
Company, Meditrina Pharmaceuticals, AstraZeneca plc, Pfizer, Inc., Bayer
HealthCare Pharmaceuticals, and Neurocrine Biosciences, Inc.
No comments:
Post a Comment